STAVZOR Drug Patent Profile
✉ Email this page to a colleague
When do Stavzor patents expire, and what generic alternatives are available?
Stavzor is a drug marketed by Bionpharma and is included in one NDA.
The generic ingredient in STAVZOR is valproic acid. There are seventeen drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the valproic acid profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Stavzor
A generic version of STAVZOR was approved as valproic acid by CATALENT on October 29th, 1991.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for STAVZOR?
- What are the global sales for STAVZOR?
- What is Average Wholesale Price for STAVZOR?
Summary for STAVZOR
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 144 |
| Clinical Trials: | 4 |
| Patent Applications: | 4,425 |
| DailyMed Link: | STAVZOR at DailyMed |
Recent Clinical Trials for STAVZOR
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Barbara Ann Karmanos Cancer Institute | Phase 1 |
| Sidney Kimmel Cancer Center at Thomas Jefferson University | Phase 2 |
| Pfizer | Phase 2 |
US Patents and Regulatory Information for STAVZOR
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bionpharma | STAVZOR | valproic acid | CAPSULE, DELAYED RELEASE;ORAL | 022152-001 | Jul 29, 2008 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Bionpharma | STAVZOR | valproic acid | CAPSULE, DELAYED RELEASE;ORAL | 022152-002 | Jul 29, 2008 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Bionpharma | STAVZOR | valproic acid | CAPSULE, DELAYED RELEASE;ORAL | 022152-003 | Jul 29, 2008 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
